Faculty Bibliography

Try a new search

Format these results:

Searched for:

in-biosketch:true

person:ettina02

Total Results:

165

Epilepsia. 1997:38(Suppl 8).DOI:

Parental perceptions of adolescent self-report of psychiatric disturbance in pediatric epilepsy and in attention deficit disorder [Meeting Abstract]

Vitale, SA; Weisbrot, DM; Gadow, KD; Nolan, EE; Lenn, NJ; Andriola, MR; Eng, W; Augustine, A; Hermann, BP; Ettinger, Alan B
ORIGINAL:0016245
ISSN: 1528-1167
CID: 5362072
Epilepsia. 1997:38(Suppl 8).DOI:

Psychiatric disturbances in pediatric patients with epilepsy and patients with attention deficit hyperactivity disorder [Meeting Abstract]

Weisbrot, DM; Gadow, KG; Nolan, EE; Lenn, NJ; Andriola, MR; Vitale, SA; Eng, W; Hermann, BP; Ettinger, Alan B
ORIGINAL:0016246
ISSN: 1528-1167
CID: 5362082
Epilepsia. 1997:38(Suppl 8).DOI:

Positive psychotropic effects of lamotrigine in epilepsy patients with mental retardation [Meeting Abstract]

Saracco, J; Weisbrot, DM; Dhoon, AM; Kanner, AM; Ettinger, Alan B
ORIGINAL:0016247
ISSN: 1528-1167
CID: 5362092
Epilepsia. 1996:37(5):503-5.DOI: 10.1111/j.1528-1157.1996.tb00599.x

Felbamate-induced headache

Ettinger, A B; Jandorf, L; Berdia, A; Andriola, M R; Krupp, L B; Weisbrot, D M
We prospectively investigated drug-induced headaches (HA) among 60 epileptic patients receiving felbamate (FBM). Twenty patients (33%) experienced HA. HA was pounding in 11 (55%), steady in 9 (45%), moderate or severe in 19 (95%), occurred at least once a week in all patients, and was relieved by nonnarcotic analgesics in 14 (70%). Mean duration on FBM before HA onset was 19 days. HA occurred with higher FBM doses and was relieved in 8 of 13 patients (62%) with FBM dose reduction. FBM was discontinued in most cases because of risks of anemia or hepatitis; not because of HA. Other side effects included insomnia (25%), gastrointestinal symptoms (27%), and agitation or restlessness (23%). HA is a common dose-related complication of FBM, occurs early after initiation of FBM treatment, and is relieved by dose reduction.
PMID: 8617182
ISSN: 0013-9580
CID: 1682982
Epilepsia. 1996:Supp. 5:3-3.DOI:

Anxiety in epilepsy [Meeting Abstract]

Francis, Sheeja; Weisbrot, Deborah M; Jandorf, Lina; Krupp, Lauren B; Ettinger, Alan B
ORIGINAL:0011359
ISSN: 0013-9580
CID: 2235472
Quarterly review of biology. 1996:71(1).DOI:

Epilepsy and the Functional Anatomy of the Frontal Lobe. Herbert H. Jasper , Silvana Riggio , Patricia S. Goldman-Rakic [Book Review]

Ettinger, Alan B
ORIGINAL:0016281
ISSN: 0033-5770
CID: 5363542

Coma

Chapter by: Ettinger, Alan B
in: Pocket companion to Principles & practice of medical intensive care by Kruse, James A [Ed]
Philadelphia : W.B. Saunders, c1996
pp. ?-
ISBN: 9780721656335
CID: 5356102

Seizures and status epilepticus

Chapter by: Ettinger, Alan B
in: Pocket companion to Principles & practice of medical intensive care by Kruse, James A [Ed]
Philadelphia : W.B. Saunders, c1996
pp. ?-
ISBN: 9780721656335
CID: 5356112

Neurophysiologicl monitoring and intracranial hypertension

Chapter by: Shady, M; Ettinger, Alan B
in: Pocket companion to Principles & practice of medical intensive care by Kruse, James A [Ed]
Philadelphia : W.B. Saunders, c1996
pp. ?-
ISBN: 9780721656335
CID: 5356122
Epilepsia. 1996:37.DOI:

Outcome and insight in an adult population with non-epileptic seizures [Meeting Abstract]

Manne, MK; Weisbrot, DM; Jandorf, L; Molloy, B; Bolton, AK; Ettinger, Alan B
ORIGINAL:0016243
ISSN: 1528-1167
CID: 5362052